Sancilio & Company and Ocean Blue(R) Partners with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sancilio & Company and Ocean Blue(R) Partners with Walgreens(R) in Support of Vitamin Angels(R)

PALM BEACH COUNTY, Fla., June 10, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Sancilio & Company is announcing that their Ocean Blue® brand of natural supplements is teaming up with Walgreens® in support of the Vitamin Angels program. For 20 years, Vitamin Angels has been assisting people in at-risk demographic groups who are in need. Specifically targeting pregnant women, new mothers, and children under five years of age, the non-profit organization helps them gain access to critical lifesaving and potentially life changing vitamins and minerals.

Now through the end of 2017, proceeds of Ocean Blue® product sales at Walgreens® nationwide will go toward helping provide vitamins and supplements to at-risk population groups, including millions of children in the U.S. and around the world. Last year, Vitamin Angels®, Walgreens®, Sancilio & Company and other participating vendors were able to reach more than 18 million children through these efforts. The goal is 100 million for 2014.

The Vitamin Angels® program has received a 4 out of 4 star rating from Charity Navigator for six straight years and provides over 90% of its donations to its programs. Customers are being made aware of the program through in-store signage, call-outs in their circulars, and online.

Consumers are invited to join in the effort by supporting participating brands like Ocean Blue® at their neighborhood Walgreens® stores.

About Sancilio & Company

Sancilio & Company is an American based biopharmaceutical company focused on Advanced Lipid TechnologyTM (ALT) with research, development and manufacturing of cardiovascular, dental and women's health products. It is dedicated to using this technology to develop, manufacture and distribute superior health maintenance and disease preventive products for the benefit of American consumers. Every product in its Ocean Blue® omega-3 supplement line is manufactured at its cGMP facility in Riviera Beach, Florida using its unique molecular distillation process to ensure the highest purity and quality. Their website may be viewed at http://www.sancilio.com .

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/06/prweb11929269.htm

Sancilio & Company, Inc. Chad Harrell, Vice President, Commercial Operations +1 (561) 899-4113

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles